Member Info for T0n1c

I just want to say this board seems far more civilised than others I read, even in spite of the news today
Makes for a very pleasant change.

Long may it last.

Hey HyperMarlin.. all good, to some extent, over at ODX. A waiting game, as you say.
I've looked in here a few times. I would have had a SB on here some time back had IG allowed, but thankfully, today, they don't let you open positions.
So I've top sliced some of my ODX to take a position here in the ISA instead.
It feels as though ABC-19 will, eventually, do well in the 30 or so countries showing interest.
AVCT are due to CE mark their test in the coming weeks.
It just feels as though today is very much overdone.

I'm in... Hi everyone. Happy with 54.8.
Way oversold.
The RNS didn't read brilliantly, but there is so much potential and news to come here and across the UK LFT manufacturers in general.
Sorry for those in the red, today, but I think it will come good.
GLA

I don't read that ABDX, and the consortium, are tied to the UK Gov.
ABDX, not ODX, have outstanding issues with payments from them, but ABDX seem to be focusing on production, and an order pipeline, for other clients.
In the ABDX interim results it said;
"The Company is making good progress in the approval of AbC-19™ for testing in the US as well as with over 30 other countries worldwide. The Company has identified customers in seven countries that are being prioritised internally as Tier 1 commercial targets where, following registration of AbC-19™, the Company anticipates significant sizeable orders, ahead of the end of Abingdon Health's financial year. At this stage, the Tier 2 commercial targets are not anticipated to convert until the next financial year."
They have just said that's going slower than anticipated, but there are still multiple customers/countries out there to purchase what the consortium make.

I read that as, there was a contract (we saw it on Bidstats) awarded to ABDX for an amount (£6.7m) to procure the required materials, on behalf of the consortium, to manufacture the tests.
My understanding of the Omega arrangement, to date at least, is that the UK Gov directly purchased the equipment from the manufacturer and have then loaned that equipment to Omega, so we are not due any reimbursement for costs.

If you look back at the last ShareBuyers Q&A
* How confident are you in fulfilling that 2m capacity per week?
I think you can safely assume that we wouldn’t be building up capacity to produce 2m tests per week or ramping up our staffing levels considerably across the group if we didn’t think we would have the demand for the lateral flow tests that we can produce.

* Worst-case assumption that the DHSC doesn’t fill your production capacity, where else do opportunities lie for Omega Diagnostics?
I don’t think that’s a realistic scenario. We’ve been working closely with the DHSC for some time and they’ve been keen to support the build up our production capacity by lending us the machinery and equipment we need. The Government themselves have said that they are looking for significant manufacturing capacity to supply tests to support their plan to cautiously ease lock-down restrictions. I don’t see this worst-scenario coming to pass.

"Abingdon, alongside its UK Rapid Test Consortium partners, continues to make progress on commercialising the AbC-19TM rapid test both in the UK private sector and internationally. The Board is encouraged by the ongoing commercial discussions whilst progressing the required regulatory approvals, and continues to advance its Tier 1 order pipeline, as outlined at the time of the interim results. Further progress has been made in each of these seven countries and the pipeline of opportunities also continues to grow. In anticipation of these near-term opportunities, the Company continues to build AbC-19TM rapid test stock alongside its consortium partners so that Abingdon can quickly satisfy demand as orders are confirmed."

The last sentence is the one to take onboard.

@TakingEasy.. a recent Omega tweet;
https://twitter.com/OmegaDiagnostic/status/1367430578627371013

They were at 191 in January, and planning for 250+ April 21 onwards.

"A key focus for Avacta is the supply side, confirming that it has access to 5-30m tests per month (subject to access of equipment funded by the UK government), when fully scaled up, and is in discussions with OEM partners and other LFT manufacturers in overseas markets to increase this further."

Government funded equipment.

companies can't win...
They either tell investors what's going on, and reassure them it's progressing.
Or they don't publish anything, and leave the investors guessing.

Seems many "investors" are never happy.

I'm seeing the same across a number of companies I'm in/watching.
Nothing get's posted past 17:07 from what I have seen.

Sorry my ar5e....
@upomega 08:31 "Follow the bod. Sell"
@upomega 09:16 "Im sorry people are selling"

Is it all investors should hold or sell UpOmega?
Make your bloody mind up.

From the recent ShareBuyers Q&A article Colin stated;
"We don’t need a Placing because we expect to have a year-end cash position of £5.5m to £6m. We have said that the DHSC contract is expected to have a significant impact on the future performance of the business and likely to result in substantial revenue growth in the coming financial year. This would have a significant impact on our cash generation and therefore removes any need for funds from investors."
In addition they have a £2m overdraft, but I don't think they'll be needing that for a while.

Thank you Twatcher.
Appreciate your response.
Apologies for the entirely weird question. I'm intrigued by trading strategies, but fully appreciate your position on that.
Given you read to be a seasoned investor, I assume you must have a diverse PF, so can I assume you have other accounts to post on other boards?

Thank you for that. Not so many positives, from your perspective, as I read it apart from perhaps " Mologic announcement alone will be +ve for the SP. Contracts more positive."

So may I then ask, if you don't mind, why you dedicate all of your posting time to only ODX?
Do you have other accounts for other boards? (assuming you've an interest in other companies)
Are you waiting for your investment entry price (if/when the above news lands)? Your account, here, appears to have started in the 50's range, so you could/should be sitting on profit now unless averaged up over time.
Do you day trade the highs and lows?
Do you have a short (spread bet) in place from a previous high?
Are you just a Good Samaritan?

I am genuinely interested as I really can't recall, apart from your two statements I've quoted above, you being positive on ODX.

I am genuinely interested, so Twatcher I'd be grateful for your thoughts.

Do you see anything positive in Omega?

Asking for a friend.

And apologies... Good morning all.

Random question.. but I've noticed across a number of companies I'm in, or watching, no longer publish larger trades, after market close, where before they were quite prolific. Is there a change to reporting, as in we see all trades live now, or is it that there are just no significantly sized trades that are delayed in publication?
Not talking only about ODX here, as I've seen across many others too.

Cheers

I think there's a mixed bag of interest in self testing. I know many friends have ordered theirs, even without me asking them to. :-)
I do think it will pick up more when entry to places stipulates proof though.
I think there's also been a slow news weekend on the Covid front, rightly so, due to Duke passing (RIP), so no real promotion of it on that front. I think that will pick up again through the course of next week.
I still see huge potential for Omega, still think April is the start off good things to come.